Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Cell

Retrieve available abstracts of 207 articles:
HTML format

Single Articles

    May 2024
  1. HARTMANN JA, Cardoso MR, Talarico MCR, Kenney DJ, et al
    Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
    Cell. 2024;187:2393-2410.
    PubMed     Abstract available

    April 2024
  2. WAYNE CJ, Blakney AK
    Self-amplifying RNA COVID-19 vaccine.
    Cell. 2024;187:1822-1822.
    PubMed     Abstract available

    February 2024
  3. QU P, Xu K, Faraone JN, Goodarzi N, et al
    Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
    Cell. 2024;187:585-595.
    PubMed     Abstract available

  4. ZHANG L, Kempf A, Nehlmeier I, Cossmann A, et al
    SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
    Cell. 2024;187:596-608.
    PubMed     Abstract available

    December 2023
  5. MATTESON NL, Hassler GW, Kurzban E, Schwab MA, et al
    Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics.
    Cell. 2023;186:5690-5704.
    PubMed     Abstract available

    November 2023
  6. MEIJERS M, Ruchnewitz D, Eberhardt J, Luksza M, et al
    Population immunity predicts evolutionary trajectories of SARS-CoV-2.
    Cell. 2023;186:5151-5164.
    PubMed     Abstract available

    October 2023
  7. SCHMIDT N, Ganskih S, Wei Y, Gabel A, et al
    SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.
    Cell. 2023;186:4834-4850.
    PubMed     Abstract available

  8. BOUHADDOU M, Reuschl AK, Polacco BJ, Thorne LG, et al
    SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Cell. 2023;186:4597-4614.
    PubMed     Abstract available

  9. WIMMERS F, Burrell AR, Feng Y, Zheng H, et al
    Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
    Cell. 2023;186:4632-4651.
    PubMed     Abstract available

  10. WONG AC, Devason AS, Umana IC, Cox TO, et al
    Serotonin reduction in post-acute sequelae of viral infection.
    Cell. 2023 Oct 9:S0092-8674(23)01034-6. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available

    September 2023
  11. HONCE R, Schultz-Cherry S
    Looking beyond the H5 avian influenza viruses.
    Cell. 2023;186:4003-4004.
    PubMed     Abstract available

    August 2023
    Haunting innate immune memories of COVID-19.
    Cell. 2023;186:3753-3755.
    PubMed     Abstract available

  13. CHEONG JG, Ravishankar A, Sharma S, Parkhurst CN, et al
    Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
    Cell. 2023;186:3882-3902.
    PubMed     Abstract available

  14. SUN H, Li H, Tong Q, Han Q, et al
    Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets.
    Cell. 2023 Aug 24:S0092-8674(23)00891-7. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available

  15. LACRAMPE A, Hu F
    Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell.
    Cell. 2023;186:3329-3331.
    PubMed     Abstract available

  16. BAGGEN J, Jacquemyn M, Persoons L, Vanstreels E, et al
    TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
    Cell. 2023;186:3427-3442.
    PubMed     Abstract available

    July 2023
  17. FALSEY AR, Walsh EE
    Respiratory syncytial virus Prefusion F vaccine.
    Cell. 2023;186:3137-3137.
    PubMed     Abstract available

  18. TEGALLY H, Wilkinson E, Tsui JL, Moir M, et al
    Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern.
    Cell. 2023;186:3277-3290.
    PubMed     Abstract available

    May 2023
  19. ZOST SJ, Carnahan RH
    A budding new approach strengthens an important message.
    Cell. 2023;186:2283-2285.
    PubMed     Abstract available

  20. ARIETA CM, Xie YJ, Rothenberg DA, Diao H, et al
    The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
    Cell. 2023;186:2392-2409.
    PubMed     Abstract available

  21. HOFFMANN MAG, Yang Z, Huey-Tubman KE, Cohen AA, et al
    ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines.
    Cell. 2023;186:2380-2391.
    PubMed     Abstract available

  22. AHN M, Chen VC, Rozario P, Ng WL, et al
    Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases.
    Cell. 2023;186:2144-2159.
    PubMed     Abstract available

    March 2023
  23. OUDIT GY, Wang K, Viveiros A, Kellner MJ, et al
    Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
    Cell. 2023;186:906-922.
    PubMed     Abstract available

    February 2023
  24. NEIL SJD
    Pangolin merbecovirus gets down to (poly)basics.
    Cell. 2023;186:688-690.
    PubMed     Abstract available

  25. DADONAITE B, Crawford KHD, Radford CE, Farrell AG, et al
    A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.
    Cell. 2023 Feb 13:S0092-8674(23)00103-4. doi: 10.1016/j.cell.2023.
    PubMed     Abstract available

  26. ROSAIN J, Neehus AL, Manry J, Yang R, et al
    Human IRF1 governs macrophagic IFN-gamma immunity to mycobacteria.
    Cell. 2023;186:621-645.
    PubMed     Abstract available

    January 2023
  27. WANG Q, Iketani S, Li Z, Liu L, et al
    Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
    Cell. 2023;186:279-286.
    PubMed     Abstract available

  28. WU CT, Lidsky PV, Xiao Y, Cheng R, et al
    SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.
    Cell. 2023;186:112-130.
    PubMed     Abstract available

  29. DE CARVALHO RVH, Ersching J, Barbulescu A, Hobbs A, et al
    Clonal replacement sustains long-lived germinal centers primed by respiratory viruses.
    Cell. 2023;186:131-146.
    PubMed     Abstract available

    December 2022
  30. BARTSCH YC, Cizmeci D, Kang J, Zohar T, et al
    Antibody effector functions are associated with protection from respiratory syncytial virus.
    Cell. 2022;185:4873-4886.
    PubMed     Abstract available

    November 2022
  31. YAN L, Huang Y, Ge J, Liu Z, et al
    A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
    Cell. 2022;185:4347-4360.
    PubMed     Abstract available

  32. BUCKNER CM, Kardava L, El Merhebi O, Narpala SR, et al
    Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses.
    Cell. 2022;185:4333-4346.
    PubMed     Abstract available

  33. LE NOUEN C, Nelson CE, Liu X, Park HS, et al
    Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys.
    Cell. 2022 Nov 10:S0092-8674(22)01418-0. doi: 10.1016/j.cell.2022.
    PubMed     Abstract available

    October 2022
  34. PHILIPS RL, Wang Y, Cheon H, Kanno Y, et al
    The JAK-STAT pathway at 30: Much learned, much more to do.
    Cell. 2022;185:3857-3876.
    PubMed     Abstract available

  35. KIMURA I, Yamasoba D, Tamura T, Nao N, et al
    Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
    Cell. 2022;185:3992-4007.
    PubMed     Abstract available

  36. TAFT JM, Weber CR, Gao B, Ehling RA, et al
    Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
    Cell. 2022;185:4008-4022.
    PubMed     Abstract available

    September 2022
  37. ACHARYA D, Reis R, Volcic M, Liu G, et al
    Actin cytoskeleton remodeling primes RIG-I-like receptor activation.
    Cell. 2022;185:3588-3602.
    PubMed     Abstract available

  38. FRANK F, Keen MM, Rao A, Bassit L, et al
    Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
    Cell. 2022;185:3603-3616.
    PubMed     Abstract available

  39. ROTHENBURG S, Yang Z, Beard P, Sawyer SL, et al
    Monkeypox emergency: Urgent questions and perspectives.
    Cell. 2022;185:3279-3281.
    PubMed     Abstract available

    August 2022
  40. CASANOVA JL, Abel L
    From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.
    Cell. 2022;185:3086-3103.
    PubMed     Abstract available

  41. DOLTON G, Rius C, Hasan MS, Wall A, et al
    Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
    Cell. 2022;185:2936-2951.
    PubMed     Abstract available

  42. LI L, Liao H, Meng Y, Li W, et al
    Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1.
    Cell. 2022;185:2952-2960.
    PubMed     Abstract available

    July 2022
  43. TUEKPRAKHON A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, et al
    Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
    Cell. 2022;185:2422-2433.
    PubMed     Abstract available

  44. KAO J, Frankland PW
    COVID fog demystified.
    Cell. 2022;185:2391-2393.
    PubMed     Abstract available

  45. FERNANDEZ-CASTANEDA A, Lu P, Geraghty AC, Song E, et al
    Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
    Cell. 2022;185:2452-2468.
    PubMed     Abstract available

  46. ZHANG Z, Mateus J, Coelho CH, Dan JM, et al
    Humoral and cellular immune memory to four COVID-19 vaccines.
    Cell. 2022;185:2434-2451.
    PubMed     Abstract available

    June 2022
  47. XU K, Gao P, Liu S, Lu S, et al
    Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2.
    Cell. 2022;185:2265-2278.
    PubMed     Abstract available

  48. NUTALAI R, Zhou D, Tuekprakhon A, Ginn HM, et al
    Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
    Cell. 2022;185:2116-2131.
    PubMed     Abstract available

  49. YAMASOBA D, Kimura I, Nasser H, Morioka Y, et al
    Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Cell. 2022;185:2103-2115.
    PubMed     Abstract available

  50. CHATURVEDI S, Pablo M, Wolf M, Rosas-Rivera D, et al
    Disrupting autorepression circuitry generates "open-loop lethality" to yield escape-resistant antiviral agents.
    Cell. 2022;185:2086-2102.
    PubMed     Abstract available

    May 2022
  51. YEUNG ML, Teng JLL, Yuen KY
    Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1840-1841.

  52. BATLLE D, Monteil V, Garreta E, Hassler L, et al
    Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.
    Cell. 2022;185:1837-1839.

  53. GOEL RR, Painter MM, Lundgreen KA, Apostolidis SA, et al
    Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.
    Cell. 2022;185:1875-1887.
    PubMed     Abstract available

    April 2022
  54. YING B, Scheaffer SM, Whitener B, Liang CY, et al
    Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
    Cell. 2022;185:1572-1587.
    PubMed     Abstract available

  55. GAGNE M, Moliva JI, Foulds KE, Andrew SF, et al
    mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
    Cell. 2022;185:1556-1571.
    PubMed     Abstract available

  56. SERVELLITA V, Syed AM, Morris MK, Brazer N, et al
    Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
    Cell. 2022;185:1539-1548.
    PubMed     Abstract available

  57. CHANDRASHEKAR A, Yu J, McMahan K, Jacob-Dolan C, et al
    Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
    Cell. 2022;185:1549-1555.
    PubMed     Abstract available

  58. RODDA LB, Morawski PA, Pruner KB, Fahning ML, et al
    Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
    Cell. 2022;185:1588-1601.
    PubMed     Abstract available

  59. Bringing research to the intensive care setting.
    Cell. 2022;185:1275-1278.
    PubMed     Abstract available

  60. Learning lessons from lipids to make COVID-19 vaccines.
    Cell. 2022;185:1279-1282.
    PubMed     Abstract available

  61. LI C, Zhan W, Yang Z, Tu C, et al
    Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
    Cell. 2022;185:1389-1401.
    PubMed     Abstract available

  62. YEN M, Ren J, Liu Q, Glassman CR, et al
    Facile discovery of surrogate cytokine agonists.
    Cell. 2022;185:1414-1430.
    PubMed     Abstract available

  63. QU L, Yi Z, Shen Y, Lin L, et al
    Circular RNA vaccines against SARS-CoV-2 and emerging variants.
    Cell. 2022 Apr 1. pii: S0092-8674(22)00394-4. doi: 10.1016/j.cell.2022.
    PubMed     Abstract available

    March 2022
  64. TANGYE SG, Burnett DL, Bull RA
    Getting to the (germinal) center of humoral immune responses to SARS-CoV-2.
    Cell. 2022;185:945-948.
    PubMed     Abstract available

  65. ZAZHYTSKA M, Kodra A, Hoagland DA, Frere J, et al
    Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
    Cell. 2022;185:1052-1064.
    PubMed     Abstract available

  66. ROLTGEN K, Nielsen SCA, Silva O, Younes SF, et al
    Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.
    Cell. 2022;185:1025-1040.
    PubMed     Abstract available

  67. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
    Cell. 2022;185:916-938.
    PubMed     Abstract available

  68. SU Y, Yuan D, Chen DG, Ng RH, et al
    Multiple early factors anticipate post-acute COVID-19 sequelae.
    Cell. 2022;185:881-895.
    PubMed     Abstract available

  69. AFKHAMI S, D'Agostino MR, Zhang A, Stacey HD, et al
    Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
    Cell. 2022;185:896-915.
    PubMed     Abstract available

  70. TARKE A, Coelho CH, Zhang Z, Dan JM, et al
    SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
    Cell. 2022;185:847-859.
    PubMed     Abstract available

  71. CUI Z, Liu P, Wang N, Wang L, et al
    Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.
    Cell. 2022;185:860-871.
    PubMed     Abstract available

    February 2022
  72. BORRIELLO F, Poli V, Shrock E, Spreafico R, et al
    An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.
    Cell. 2022;185:614-629.
    PubMed     Abstract available

  73. MUDD PA, Minervina AA, Pogorelyy MV, Turner JS, et al
    SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.
    Cell. 2022;185:603-613.
    PubMed     Abstract available

    Omicron's message on vaccines: Boosting begets breadth.
    Cell. 2022;185:411-413.
    PubMed     Abstract available

  75. SIDDLE KJ, Krasilnikova LA, Moreno GK, Schaffner SF, et al
    Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak.
    Cell. 2022;185:485-492.
    PubMed     Abstract available

  76. GEORG P, Astaburuaga-Garcia R, Bonaguro L, Brumhard S, et al
    Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
    Cell. 2022;185:493-512.
    PubMed     Abstract available

  77. HOFFMANN M, Kruger N, Schulz S, Cossmann A, et al
    The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
    Cell. 2022;185:447-456.
    PubMed     Abstract available

    Francis Collins: Reflections on being the NIH Director.
    Cell. 2022;185:401-406.
    PubMed     Abstract available

    December 2021
  79. GRUBAUGH ND, Cobey S
    Of variants and vaccines.
    Cell. 2021;184:6222-6223.
    PubMed     Abstract available

  80. TERMINI CM, Rutaganira FUN, Palavicino-Maggio CB, Spriggs CC, et al
    Using virtual interviewing to create a more accessible hybrid academic job market.
    Cell. 2021;184:6217-6221.
    PubMed     Abstract available

  81. WENDISCH D, Dietrich O, Mari T, von Stillfried S, et al
    SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
    Cell. 2021;184:6243-6261.
    PubMed     Abstract available

  82. BUSHMAN M, Kahn R, Taylor BP, Lipsitch M, et al
    Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.
    Cell. 2021;184:6229-6242.
    PubMed     Abstract available

  83. BRIAND SC, Cinelli M, Nguyen T, Lewis R, et al
    Infodemics: A new challenge for public health.
    Cell. 2021;184:6010-6014.
    PubMed     Abstract available

  84. XIAO Y, Lidsky PV, Shirogane Y, Aviner R, et al
    A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
    Cell. 2021;184:6037-6051.
    PubMed     Abstract available

  85. CHATURVEDI S, Vasen G, Pablo M, Chen X, et al
    Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance.
    Cell. 2021;184:6022-6036.
    PubMed     Abstract available

    November 2021
  86. KHAN M, Yoo SJ, Clijsters M, Backaert W, et al
    Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.
    Cell. 2021;184:5932-5949.
    PubMed     Abstract available

  87. KUMAR S, Javed R, Mudd M, Pallikkuth S, et al
    Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes.
    Cell. 2021;184:5950-5969.
    PubMed     Abstract available

  88. PAYNE RP, Longet S, Austin JA, Skelly DT, et al
    Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
    Cell. 2021;184:5699-5714.
    PubMed     Abstract available

    October 2021
  89. CROSS G, Ho JSY, Zacharias W, Jeyasekharan AD, et al
    Emergency drug use in a pandemic: Harsh lessons from COVID-19.
    Cell. 2021;184:5497-5500.
    PubMed     Abstract available

  90. Persistent progress.
    Cell. 2021;184:5293-5296.
    PubMed     Abstract available

  91. SHAPIRO L, Losick R
    Delivering the message: How a novel technology enabled the rapid development of effective vaccines.
    Cell. 2021;184:5271-5274.
    PubMed     Abstract available

    September 2021
  92. MARTIN DP, Weaver S, Tegally H, San JE, et al
    The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages.
    Cell. 2021;184:5189-5200.
    PubMed     Abstract available

  93. CEVIK M, Grubaugh ND, Iwasaki A, Openshaw P, et al
    COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cell. 2021;184:5077-5081.
    PubMed     Abstract available

  94. JACKSON B, Boni MF, Bull MJ, Colleran A, et al
    Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic.
    Cell. 2021;184:5179-5188.
    PubMed     Abstract available

  95. Building and supporting identity in peer review.
    Cell. 2021;184:5071-5072.

  96. ZELLER M, Gangavarapu K, Anderson C, Smither AR, et al
    Emergence of an early SARS-CoV-2 epidemic in the United States.
    Cell. 2021;184:4939-4952.
    PubMed     Abstract available

  97. SPOSITO B, Broggi A, Pandolfi L, Crotta S, et al
    The interferon landscape along the respiratory tract impacts the severity of COVID-19.
    Cell. 2021;184:4953-4968.
    PubMed     Abstract available

  98. HOLMES EC, Goldstein SA, Rasmussen AL, Robertson DL, et al
    The origins of SARS-CoV-2: A critical review.
    Cell. 2021;184:4848-4856.
    PubMed     Abstract available

  99. ZIEGLER CGK, Miao VN, Owings AH, Navia AW, et al
    Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Cell. 2021;184:4713-4733.
    PubMed     Abstract available

    August 2021
  100. KARLSSON EA, Duong V
    The continuing search for the origins of SARS-CoV-2.
    Cell. 2021;184:4373-4374.
    PubMed     Abstract available

  101. KANG L, He G, Sharp AK, Wang X, et al
    A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.
    Cell. 2021;184:4392-4400.
    PubMed     Abstract available

  102. NATHAN A, Rossin EJ, Kaseke C, Park RJ, et al
    Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Cell. 2021;184:4401-4413.
    PubMed     Abstract available

  103. ZHOU H, Ji J, Chen X, Bi Y, et al
    Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.
    Cell. 2021;184:4380-4391.
    PubMed     Abstract available

  104. LIU C, Ginn HM, Dejnirattisai W, Supasa P, et al
    Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
    Cell. 2021;184:4220-4236.
    PubMed     Abstract available

  105. LI D, Edwards RJ, Manne K, Martinez DR, et al
    In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
    Cell. 2021;184:4203-4219.
    PubMed     Abstract available

    July 2021
    Unraveling the long-term effect of influenza vaccines.
    Cell. 2021;184:3845-3847.
    PubMed     Abstract available

  107. WEINGARTEN-GABBAY S, Klaeger S, Sarkizova S, Pearlman LR, et al
    Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Cell. 2021;184:3962-3980.
    PubMed     Abstract available

  108. COPIN R, Baum A, Wloga E, Pascal KE, et al
    The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
    Cell. 2021;184:3949-3961.
    PubMed     Abstract available

    June 2021
  109. YAN L, Yang Y, Li M, Zhang Y, et al
    Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
    Cell. 2021;184:3474-3485.
    PubMed     Abstract available

  110. LIU K, Pan X, Li L, Yu F, et al
    Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species.
    Cell. 2021;184:3438-3451.
    PubMed     Abstract available

  111. LIU Y, Soh WT, Kishikawa JI, Hirose M, et al
    An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
    Cell. 2021;184:3452-3466.
    PubMed     Abstract available

  112. HE X, Chandrashekar A, Zahn R, Wegmann F, et al
    Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
    Cell. 2021;184:3467-3473.
    PubMed     Abstract available

  113. HAO Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, et al
    Integrated analysis of multimodal single-cell data.
    Cell. 2021;184:3573-3587.
    PubMed     Abstract available

  114. DENG X, Garcia-Knight MA, Khalid MM, Servellita V, et al
    Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
    Cell. 2021;184:3426-3437.
    PubMed     Abstract available

  115. WIMMERS F, Donato M, Kuo A, Ashuach T, et al
    The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.
    Cell. 2021 Jun 22. pii: S0092-8674(21)00692-9. doi: 10.1016/j.cell.2021.
    PubMed     Abstract available

  116. CORTI D, Purcell LA, Snell G, Veesler D, et al
    Tackling COVID-19 with neutralizing monoclonal antibodies.
    Cell. 2021;184:3086-3108.
    PubMed     Abstract available

  117. SCHEID JF, Barnes CO, Eraslan B, Hudak A, et al
    B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
    Cell. 2021;184:3205-3221.
    PubMed     Abstract available

  118. ASARNOW D, Wang B, Lee WH, Hu Y, et al
    Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
    Cell. 2021;184:3192-3204.
    PubMed     Abstract available

    May 2021
  119. BAUMER Y, Powell-Wiley TM
    Interdisciplinary approaches are fundamental to decode the biology of adversity.
    Cell. 2021;184:2797-2801.
    PubMed     Abstract available

  120. GARRETT ME, Galloway J, Chu HY, Itell HL, et al
    High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
    Cell. 2021;184:2927-2938.
    PubMed     Abstract available

  121. DEJNIRATTISAI W, Zhou D, Supasa P, Liu C, et al
    Antibody evasion by the P.1 strain of SARS-CoV-2.
    Cell. 2021;184:2939-2954.
    PubMed     Abstract available

  122. WILLIAMS WB, Meyerhoff RR, Edwards RJ, Li H, et al
    Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
    Cell. 2021 May 18. pii: S0092-8674(21)00577-8. doi: 10.1016/j.cell.2021.
    PubMed     Abstract available

  123. ALPERT T, Brito AF, Lasek-Nesselquist E, Rothman J, et al
    Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
    Cell. 2021;184:2595-2604.
    PubMed     Abstract available

  124. WASHINGTON NL, Gangavarapu K, Zeller M, Bolze A, et al
    Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
    Cell. 2021;184:2587-2594.
    PubMed     Abstract available

  125. HO JSY, Mok BW, Campisi L, Jordan T, et al
    TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
    Cell. 2021;184:2618-2632.
    PubMed     Abstract available

  126. CLARK SA, Clark LE, Pan J, Coscia A, et al
    SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
    Cell. 2021;184:2605-2617.
    PubMed     Abstract available

  127. QIU X, Hanage WP, Taylor BP
    Coming to America: Genomic surveillance and how B.1.1.7 arrived in the US.
    Cell. 2021;184:2532-2534.
    PubMed     Abstract available

    April 2021
  128. LEBLANC EV, Colpitts CC
    SARS-CoV-2 RNA: Exclusive friends and common foes.
    Cell. 2021;184:2276-2278.
    PubMed     Abstract available

  129. BOEHM JS
    The power of parent scientists.
    Cell. 2021;184:2263-2270.
    PubMed     Abstract available

  130. HOFFMANN M, Arora P, Gross R, Seidel A, et al
    SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Cell. 2021;184:2384-2393.
    PubMed     Abstract available

  131. SURYADEVARA N, Shrihari S, Gilchuk P, VanBlargan LA, et al
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
    Cell. 2021;184:2316-2331.
    PubMed     Abstract available

  132. FABIUS JM, Krogan NJ
    Creating collaboration by breaking down scientific barriers.
    Cell. 2021;184:2271-2275.
    PubMed     Abstract available

  133. MCCALLUM M, De Marco A, Lempp FA, Tortorici MA, et al
    N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
    Cell. 2021;184:2332-2347.
    PubMed     Abstract available

  134. GARCIA-BELTRAN WF, Lam EC, St Denis K, Nitido AD, et al
    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
    Cell. 2021;184:2372-2383.
    PubMed     Abstract available

  135. FLYNN RA, Belk JA, Qi Y, Yasumoto Y, et al
    Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
    Cell. 2021;184:2394-2411.
    PubMed     Abstract available

  136. ZHOU D, Dejnirattisai W, Supasa P, Liu C, et al
    Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
    Cell. 2021;184:2348-2361.
    PubMed     Abstract available

  137. The origins of viral infection sleuth.
    Cell. 2021;184:1960-1961.
    PubMed     Abstract available

  138. SCHNEIDER JL, Rowe JH, Garcia-de-Alba C, Kim CF, et al
    The aging lung: Physiology, disease, and immunity.
    Cell. 2021;184:1990-2019.
    PubMed     Abstract available

  139. MILLS RJ, Humphrey SJ, Fortuna PRJ, Lor M, et al
    BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Cell. 2021;184:2167-2182.
    PubMed     Abstract available

  140. DEJNIRATTISAI W, Zhou D, Ginn HM, Duyvesteyn HME, et al
    The antigenic anatomy of SARS-CoV-2 receptor binding domain.
    Cell. 2021;184:2183-2200.
    PubMed     Abstract available

  141. SUPASA P, Zhou D, Dejnirattisai W, Liu C, et al
    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
    Cell. 2021;184:2201-2211.
    PubMed     Abstract available

  142. YEUNG ML, Teng JLL, Jia L, Zhang C, et al
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Cell. 2021;184:2212-2228.
    PubMed     Abstract available

  143. ZHANG X, Liu Y, Liu J, Bailey AL, et al
    A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
    Cell. 2021;184:2229-2238.
    PubMed     Abstract available

    One world, one health.
    Cell. 2021;184:1956-1959.
    PubMed     Abstract available

  145. SCHULTZE JL, Aschenbrenner AC
    COVID-19 and the human innate immune system.
    Cell. 2021;184:1671-1692.
    PubMed     Abstract available

  146. YU B, Qi Y, Li R, Shi Q, et al
    B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
    Cell. 2021;184:1790-1803.
    PubMed     Abstract available

  147. LIU C, Martins AJ, Lau WW, Rachmaninoff N, et al
    Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
    Cell. 2021;184:1836-1857.
    PubMed     Abstract available

  148. WINKLER ES, Gilchuk P, Yu J, Bailey AL, et al
    Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
    Cell. 2021;184:1804-1820.
    PubMed     Abstract available

  149. ANDREANO E, Nicastri E, Paciello I, Pileri P, et al
    Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
    Cell. 2021;184:1821-1835.
    PubMed     Abstract available

  150. REN X, Wen W, Fan X, Hou W, et al
    COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
    Cell. 2021;184:1895-1913.
    PubMed     Abstract available

  151. SUN L, Li P, Ju X, Rao J, et al
    In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
    Cell. 2021;184:1865-1883.
    PubMed     Abstract available

  152. ANDERSON EM, Goodwin EC, Verma A, Arevalo CP, et al
    Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
    Cell. 2021;184:1858-1864.
    PubMed     Abstract available

    March 2021
  153. GEBRE MS, Brito LA, Tostanoski LH, Edwards DK, et al
    Novel approaches for vaccine development.
    Cell. 2021;184:1589-1603.
    PubMed     Abstract available

  154. SANDRONE S, Scott G, Anderson WJ, Musunuru K, et al
    Active learning-based STEM education for in-person and online learning.
    Cell. 2021;184:1409-1414.
    PubMed     Abstract available

  155. Scientific misinformation: A perfect storm, missteps, and moving forward.
    Cell. 2021;184:1402-1406.
    PubMed     Abstract available

  156. TOPOL EJ
    Messenger RNA vaccines against SARS-CoV-2.
    Cell. 2021;184:1401.
    PubMed     Abstract available

  157. PILLON NJ, Loos RJF, Marshall SM, Zierath JR, et al
    Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Cell. 2021;184:1530-1544.
    PubMed     Abstract available

  158. MANN ME, Hall LJ, Dulvy NK
    Scientific impact in a changing world.
    Cell. 2021;184:1407-1408.
    PubMed     Abstract available

  159. THOMSON EC, Rosen LE, Shepherd JG, Spreafico R, et al
    Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Cell. 2021;184:1171-1187.
    PubMed     Abstract available

  160. GRUBAUGH ND, Hodcroft EB, Fauver JR, Phelan AL, et al
    Public health actions to control new SARS-CoV-2 variants.
    Cell. 2021;184:1127-1132.
    PubMed     Abstract available

  161. BROUWER PJM, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, et al
    Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
    Cell. 2021;184:1188-1200.
    PubMed     Abstract available

  162. SOKAL A, Chappert P, Barba-Spaeth G, Roeser A, et al
    Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
    Cell. 2021;184:1201-1213.
    PubMed     Abstract available

    February 2021
  163. LI Q, Nie J, Wu J, Zhang L, et al
    SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
    Cell. 2021 Feb 23. pii: S0092-8674(21)00231-2. doi: 10.1016/j.cell.2021.
    PubMed     Abstract available

  164. SETTE A, Crotty S
    Adaptive immunity to SARS-CoV-2 and COVID-19.
    Cell. 2021;184:861-880.
    PubMed     Abstract available

  165. NIE X, Qian L, Sun R, Huang B, et al
    Multi-organ proteomic landscape of COVID-19 autopsies.
    Cell. 2021;184:775-791.
    PubMed     Abstract available

  166. ATYEO C, Pullen KM, Bordt EA, Fischinger S, et al
    Compromised SARS-CoV-2-specific placental antibody transfer.
    Cell. 2021;184:628-642.
    PubMed     Abstract available

    January 2021
  167. GARCIA-BELTRAN WF, Lam EC, Astudillo MG, Yang D, et al
    COVID-19-neutralizing antibodies predict disease severity and survival.
    Cell. 2021;184:476-488.
    PubMed     Abstract available

  168. HOANG TN, Pino M, Boddapati AK, Viox EG, et al
    Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
    Cell. 2021;184:460-475.
    PubMed     Abstract available

  169. What happens next.
    Cell. 2021;184:291-292.

  170. HOFFMANN HH, Schneider WM, Rozen-Gagnon K, Miles LA, et al
    TMEM41B Is a Pan-flavivirus Host Factor.
    Cell. 2021;184:133-148.
    PubMed     Abstract available

  171. WANG R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, et al
    Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Cell. 2021;184:106-119.
    PubMed     Abstract available

  172. RODDA LB, Netland J, Shehata L, Pruner KB, et al
    Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Cell. 2021;184:169-183.
    PubMed     Abstract available

  173. KARKI R, Sharma BR, Tuladhar S, Williams EP, et al
    Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Cell. 2021;184:149-168.
    PubMed     Abstract available

  174. VOLZ E, Hill V, McCrone JT, Price A, et al
    Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Cell. 2021;184:64-75.
    PubMed     Abstract available

  175. DANILOSKI Z, Jordan TX, Wessels HH, Hoagland DA, et al
    Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Cell. 2021;184:92-105.
    PubMed     Abstract available

  176. WEI J, Alfajaro MM, DeWeirdt PC, Hanna RE, et al
    Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Cell. 2021;184:76-91.
    PubMed     Abstract available

    December 2020
  177. AVANZATO VA, Matson MJ, Seifert SN, Pryce R, et al
    Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
    Cell. 2020;183:1901-1912.
    PubMed     Abstract available

  178. ZOHAR T, Loos C, Fischinger S, Atyeo C, et al
    Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
    Cell. 2020;183:1508-1519.
    PubMed     Abstract available

  179. SU Y, Chen D, Yuan D, Lausted C, et al
    Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
    Cell. 2020;183:1479-1495.
    PubMed     Abstract available

  180. CHEN Y, Zuiani A, Fischinger S, Mullur J, et al
    Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
    Cell. 2020;183:1496-1507.
    PubMed     Abstract available

  181. GHOSH S, Dellibovi-Ragheb TA, Kerviel A, Pak E, et al
    beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
    Cell. 2020;183:1520-1535.
    PubMed     Abstract available

    November 2020
  182. WALLS AC, Fiala B, Schafer A, Wrenn S, et al
    Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
    Cell. 2020;183:1367-1382.
    PubMed     Abstract available

  183. MECKIFF BJ, Ramirez-Suastegui C, Fajardo V, Chee SJ, et al
    Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
    Cell. 2020;183:1340-1353.
    PubMed     Abstract available

  184. BANERJEE AK, Blanco MR, Bruce EA, Honson DD, et al
    SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Cell. 2020;183:1325-1339.
    PubMed     Abstract available

  185. AID M, Busman-Sahay K, Vidal SJ, Maliga Z, et al
    Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Cell. 2020;183:1354-1366.
    PubMed     Abstract available

  186. KREYE J, Reincke SM, Kornau HC, Sanchez-Sendin E, et al
    A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
    Cell. 2020;183:1058-1069.
    PubMed     Abstract available

  187. LEIST SR, Dinnon KH 3rd, Schafer A, Tse LV, et al
    A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Cell. 2020;183:1070-1085.
    PubMed     Abstract available

  188. RYDYZNSKI MODERBACHER C, Ramirez SI, Dan JM, Grifoni A, et al
    Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Cell. 2020;183:996-1012.
    PubMed     Abstract available

  189. PICCOLI L, Park YJ, Tortorici MA, Czudnochowski N, et al
    Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
    Cell. 2020;183:1024-1042.
    PubMed     Abstract available

  190. GRUBER CN, Patel RS, Trachtman R, Lepow L, et al
    Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
    Cell. 2020;183:982-995.
    PubMed     Abstract available

  191. CLAUSEN TM, Sandoval DR, Spliid CB, Pihl J, et al
    SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Cell. 2020;183:1043-1057.
    PubMed     Abstract available

  192. CONSIGLIO CR, Cotugno N, Sardh F, Pou C, et al
    The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
    Cell. 2020;183:968-981.
    PubMed     Abstract available

    October 2020
  193. YURKOVETSKIY L, Wang X, Pascal KE, Tomkins-Tinch C, et al
    Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Cell. 2020;183:739-751.
    PubMed     Abstract available

    Before Virus, After Virus: A Reckoning.
    Cell. 2020;183:308-314.
    PubMed     Abstract available

  195. IWASAKI A, Omer SB
    Why and How Vaccines Work.
    Cell. 2020;183:290-295.
    PubMed     Abstract available

    The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics.
    Cell. 2020;183:285-289.
    PubMed     Abstract available

  197. LI W, Schafer A, Kulkarni SS, Liu X, et al
    High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
    Cell. 2020;183:429-441.
    PubMed     Abstract available

  198. SEKINE T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, et al
    Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
    Cell. 2020;183:158-168.
    PubMed     Abstract available

  199. AU L, Boos LA, Swerdlow A, Byrne F, et al
    Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
    Cell. 2020;183:4-10.
    PubMed     Abstract available

  200. CANETE PF, Vinuesa CG
    COVID-19 Makes B Cells Forget, but T Cells Remember.
    Cell. 2020;183:13-15.
    PubMed     Abstract available

  201. HASSAN AO, Kafai NM, Dmitriev IP, Fox JM, et al
    A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Cell. 2020;183:169-184.
    PubMed     Abstract available

  202. IADECOLA C, Anrather J, Kamel H
    Effects of COVID-19 on the Nervous System.
    Cell. 2020;183:16-27.
    PubMed     Abstract available

  203. KANEKO N, Kuo HH, Boucau J, Farmer JR, et al
    Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
    Cell. 2020;183:143-157.
    PubMed     Abstract available

    September 2020
  204. COLUBRI A, Kemball M, Sani K, Boehm C, et al
    Preventing Outbreaks through Interactive, Experiential Real-Life Simulations.
    Cell. 2020;182:1366-1371.
    PubMed     Abstract available

  205. SCHULTE-SCHREPPING J, Reusch N, Paclik D, Bassler K, et al
    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Cell. 2020;182:1419-1440.
    PubMed     Abstract available

  206. DU S, Cao Y, Zhu Q, Yu P, et al
    Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
    Cell. 2020 Sep 14. pii: S0092-8674(20)31232-0. doi: 10.1016/j.cell.2020.
    PubMed     Abstract available

    August 2020
    Travel Less. Make It Worthwhile.
    Cell. 2020;182:790-793.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.